Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

[ad_1]

(MedPage Today) — SAN FRANCISCO — A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/croi/114653

Author :

Publish date : 2025-03-14 14:37:00

Copyright for syndicated content belongs to the linked Source.